Journal article · 2022 · Open access

Nanomedicine platform for targeting activated neutrophils and neutrophil–platelet complexes using an α1-antitrypsin-derived peptide motif

Michelle A. Cruz, Dillon J. Bohinc, Elizabeth Andraska, Jurgis Alvikas, Shruti P. Raghunathan, Nicole A. Masters, Nadine D. van Kleef, Kara L. Bane, Kathryn Hart, Kathryn Medrow, Michael T. Sun, Haitao Liu and 14 more

Nature Nanotechnology, 17(9), 1004–1014 · Published 18 July 2022 · DOI 10.1038/s41565-022-01161-w

Open PDFView at the publisherCite this paper

In brief

“Nanomedicine platform for targeting activated neutrophils and neutrophil–platelet complexes using an α1-antitrypsin-derived peptide motif” is a 2022 journal article by Michelle A. Cruz and 25 co-authors, published in Nature Nanotechnology. OpenAlex counts 111 citations as of 19 November 2026, which puts it in the top 3% of works published in 2022 by citations. It is open access: the full text is free to read at Nature Nanotechnology.

Citations
111
Most cited in
2025 (37)
Field-weighted impact
4.80
References
52
Authors
26

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Cruz, M. A., Bohinc, D. J., Andraska, E., Alvikas, J., Raghunathan, S. P., Masters, N. A., van Kleef, N. D., Bane, K. L., Hart, K., Medrow, K., Sun, M. T., Liu, H., Haldeman, S., Banerjee, A., Lessieur, E. M., Hageman, K., Gandhi, A., de la Fuente, M., Nieman, M. T., . . . Stavrou, E. X. (2022). Nanomedicine platform for targeting activated neutrophils and neutrophil–platelet complexes using an α1-antitrypsin-derived peptide motif. Nature Nanotechnology, 17(9), 1004–1014. https://doi.org/10.1038/s41565-022-01161-w

MLA 9

Cruz, Michelle A., et al. “Nanomedicine platform for targeting activated neutrophils and neutrophil–platelet complexes using an α1-antitrypsin-derived peptide motif.” Nature Nanotechnology, vol. 17, no. 9, 2022, pp. 1004–1014. https://doi.org/10.1038/s41565-022-01161-w.

Chicago

Cruz, Michelle A., Dillon J. Bohinc, Elizabeth Andraska, Jurgis Alvikas, Shruti P. Raghunathan, Nicole A. Masters, Nadine D. van Kleef, et al. 2022. “Nanomedicine platform for targeting activated neutrophils and neutrophil–platelet complexes using an α1-antitrypsin-derived peptide motif.” Nature Nanotechnology 17 (9): 1004–1014. https://doi.org/10.1038/s41565-022-01161-w.

Harvard

Cruz, M. A. et al. (2022) ‘Nanomedicine platform for targeting activated neutrophils and neutrophil–platelet complexes using an α1-antitrypsin-derived peptide motif’, Nature Nanotechnology, 17(9), pp. 1004–1014. doi:10.1038/s41565-022-01161-w.

IEEE

M. A. Cruz et al., “Nanomedicine platform for targeting activated neutrophils and neutrophil–platelet complexes using an α1-antitrypsin-derived peptide motif,” Nature Nanotechnology, vol. 17, no. 9, pp. 1004–1014, 2022, doi: 10.1038/s41565-022-01161-w.

BibTeX

@article{cruz2022nanomedicine,
  title     = {{Nanomedicine platform for targeting activated neutrophils and neutrophil–platelet complexes using an α1-antitrypsin-derived peptide motif}},
  author    = {Cruz, Michelle A. and Bohinc, Dillon J. and Andraska, Elizabeth and Alvikas, Jurgis and Raghunathan, Shruti P. and Masters, Nicole A. and van Kleef, Nadine D. and Bane, Kara L. and Hart, Kathryn and Medrow, Kathryn and Sun, Michael T. and Liu, Haitao and Haldeman, Shannon and Banerjee, Ankush and Lessieur, Emma M. and Hageman, Kara and Gandhi, Agharnan and de la Fuente, Maria and Nieman, Marvin T. and Kern, Timothy S. and Maas, Coen and de Maat, Steven and Neeves, Keith B. and Neal, Matthew D. and Gupta, Anirban Sen and Stavrou, Evi X.},
  journal   = {Nature Nanotechnology},
  year      = {2022},
  volume    = {17},
  number    = {9},
  pages     = {1004--1014},
  doi       = {10.1038/s41565-022-01161-w},
  url       = {https://doi.org/10.1038/s41565-022-01161-w}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202255
20231919
20242424
20253737
20262626

Its field-weighted citation impact is 4.80: it has been cited 4.80 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • neutrophil elastase
  • nanoparticle drug delivery
  • targeted nanomedicine
  • hydroxychloroquine
  • venous thrombosis
  • inflammation
  • platelet aggregation
  • cell-specific targeting

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Cruz, M. A., Bohinc, D. J., Andraska, E., Alvikas, J., Raghunathan, S. P., Masters, N. A., van Kleef, N. D., Bane, K. L., Hart, K., Medrow, K., Sun, M. T., Liu, H., Haldeman, S., Banerjee, A., Lessieur, E. M., Hageman, K., Gandhi, A., de la Fuente, M., Nieman, M. T., . . . Stavrou, E. X. (2022). Nanomedicine platform for targeting activated neutrophils and neutrophil–platelet complexes using an α1-antitrypsin-derived peptide motif. Nature Nanotechnology, 17(9), 1004–1014. https://doi.org/10.1038/s41565-022-01161-w

How many times has this paper been cited?

111 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Nature Nanotechnology: sign in and open the PDF from this page.

Who wrote this paper?

Michelle A. Cruz, Dillon J. Bohinc, Elizabeth Andraska, Jurgis Alvikas, Shruti P. Raghunathan, Nicole A. Masters, Nadine D. van Kleef, Kara L. Bane, Kathryn Hart, Kathryn Medrow, Michael T. Sun, Haitao Liu and 14 more.

What is the DOI of this paper?

10.1038/s41565-022-01161-w, permanently at https://doi.org/10.1038/s41565-022-01161-w. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.